The National Science Foundation (NSF) is an independent federal agency established in 1950 and based in Alexandria, Virginia. It is dedicated to supporting research and education in science and engineering across a wide range of disciplines. The NSF provides significant non-dilutive funding, up to $1.5 million, to startups and small businesses through its America's Seed Fund initiative, which is part of the Small Business Innovation Research (SBIR) program mandated by Congress. With an operating budget of approximately $7.8 billion, the NSF is committed to advancing fundamental research and education, thus fostering innovation and technological development in the United States.
TVM Capital is a global private equity and venture capital firm that backs life sciences and information technology companies across multiple stages, from seed and startup to growth equity and buyouts. The firm invests in biopharma, diagnostics, medtech, digital health, and other life-science development projects, as well as software, semiconductors, wireless, and related ICT opportunities. It typically pursues majority stakes and aims to exit through IPOs or strategic sales. Founded in 1983 and headquartered in Munich, TVM Capital maintains offices across Europe, North America, the Middle East, and Asia to support international portfolio companies. Its activities include specialized healthcare investments through affiliates focused on hospitals, clinical services, diagnostics, pharma manufacturing and distribution, and other health-care services in regions such as MENA, India, and Turkey.
NeuroOne Medical Technologies Corporation is a medical technology company based in Eden Prairie, Minnesota. It is dedicated to the development and commercialization of advanced thin film electrode technology designed for continuous electroencephalogram (cEEG) and stereoelectroencephalography (sEEG) recording. The company's focus extends to spinal cord stimulation, brain stimulation, and ablation solutions, targeting patients with conditions such as epilepsy, Parkinson’s disease, dystonia, essential tremors, and chronic pain resulting from failed back surgeries. NeuroOne aims to provide minimally invasive, high-definition solutions that enhance patient outcomes while potentially reducing procedural costs in the treatment of various neurological disorders.
EMOTIV Inc. is a bioinformatics company based in San Francisco, California, focused on developing brain wearables that enhance the understanding of the human brain through electroencephalography (EEG). The company offers a range of products, including neuroheadsets and wireless EEG devices that record and translate brainwaves, along with software solutions designed to facilitate brain-computer interface applications. EMOTIV's technologies cater to various sectors such as gaming, healthcare, robotics, automotive, and market research. Recognized as a pioneer in its field, EMOTIV has received numerous international awards for its innovative designs and contributions to brain research. Founded in 2011, the company also boasts a global community of developers and researchers, furthering advancements in brain health and cognitive potential through the application of artificial intelligence and machine learning.
MedTech Innovator is a nonprofit global competition and accelerator based in Los Angeles, California, founded in 2013. It focuses on supporting companies in the medical device, digital health, and diagnostic sectors. The organization aims to enhance patient outcomes by fostering the growth of businesses that contribute to the transformation of the healthcare system. Each year, MedTech Innovator showcases 100 companies that align with key themes identified through surveys of industry leaders. The accelerator's diverse portfolio includes firms involved in consumer healthcare, imaging, remote patient monitoring, clinical studies, and workflow optimization, emphasizing its commitment to advancing innovative healthcare solutions.
Established in 2021, Golden Falcon Capital is a venture capital firm headquartered in Wilmington, Delaware. It specializes in investing in technology companies focused on SaaS, infrastructure software, security, fintech, insurtech, commerce, artificial intelligence, analytics, and consumer tech across the United States, Israel, and emerging markets.
Founded in 2022, Impact Expansion is a Brussels-based investment firm focusing on growth capital investments in fast-growing companies with high impact business models across Western Europe. The company targets sectors such as education, healthcare, employment, and environment.
Clearway Pain Solutions Institute, LLC is a pain management medical center founded in 2013 and located in Pensacola, Florida. The institute focuses on relieving pain, restoring function, and enhancing the quality of life for patients through compassionate, patient-centered care. It offers a range of services, including interventional pain management, medication management, regenerative medicine, chiropractic care, massage therapy, and physical therapy. By employing a collaborative approach, Clearway Pain Solutions integrates the expertise of leading physicians, advanced practitioners, chiropractors, physical therapists, and dedicated support staff to empower patients to lead happier and healthier lives.
Shenzhen Capital Group Co., Ltd (SCGC) is a venture capital firm founded in 1999 by the Shenzhen Government. The company is dedicated to fostering national industries, developing national brands, and promoting economic transformation through investments in emerging sectors. SCGC primarily targets small to medium enterprises and innovative high-tech companies, focusing on those in various stages of growth, including startups and those undergoing transformation. Its investment portfolio spans industries that align with national policy support, such as information technology, internet services, new media, biopharmaceuticals, new energy, environmental protection, chemical engineering, and high-end equipment manufacturing. With a registered capital of 5.42 billion RMB and significant assets under management, SCGC has established itself as a leader in the venture capital landscape, having invested in numerous companies, many of which have achieved public listings across global capital markets.
Established in 2016, New Paradigm Investment is a company builder-type accelerator based in Seoul, South Korea. It focuses on investing in startups operating within the fourth industrial revolution and healthcare sectors, supporting their growth at various stages.
SOSV, established in 1995 and headquartered in Princeton, New Jersey, is a global venture capital firm specializing in early-stage investments. It focuses on deep tech innovations in the health and environmental sectors, supporting founders with breakthrough technologies through its HAX and IndieBio startup development programs. SOSV provides resources, facilities, and lab equipment to accelerate product development and scale, with a track record of helping its portfolio companies secure subsequent funding rounds led by top-tier investors.
Techstart Ventures is a venture capital firm based in Belfast, United Kingdom, founded in 2014. It focuses on early-stage funding, backing pre-seed and seed-stage startups. The firm positions itself as a first-cheque investor for exceptional founders pursuing global opportunities, aiming to support ventures with potential for international scale. While active across sectors, it has been associated with investments in financial services and related areas in the region, including Scotland.
Founded in 2014, eHealth Ventures is a venture capital firm based in Tel Aviv, Israel. It focuses on investing in early-stage digital health companies, particularly those specializing in digital therapeutics and diagnostics.
Founded in 2007, Innovate UK is a non-profit organization based in Swindon, UK. It supports businesses across various economic sectors by offering funding services to promote science and technology innovations.
Founded in 2014, Seven Seas Partners is a venture capital firm based in Menlo Park, California. It invests in early growth and growth-stage companies operating in consumer internet, SaaS, Internet of Things (IoT), enterprise cloud infrastructure, and services sectors across the United States and Mainland China.
Established in 1998, Enterprise Ireland is a government agency dedicated to fostering the growth of Irish businesses. It focuses on accelerating company development to achieve strong global market positions, driving national and regional prosperity.
Enhanced Capital, established in 1999, is a New York-based investment firm managing over $400 million. It specializes in providing flexible equity and debt financing to small and mid-sized businesses, promoting their growth and expansion. The firm's investment approach is practical and tailored, aiming to maximize the growth potential of companies poised for rapid growth. Enhanced Capital also invests in renewable energy, historic real estate rehabilitation, and affordable housing projects, often leveraging federal and state incentive programs.
Vine Ventures is an early-stage software-focused venture capital firm based in New York. Founded in 2020, it backs early-stage technology companies across the United States, Israel, and Latin America, with a focus on software-enabled businesses with growth potential.
WI Harper Group is a venture capital firm with cross-border operations in the United States and Greater China. Founded in 1993 and based in San Francisco, the firm maintains a presence in Beijing and Taipei and invests in early and early-expansion stages across the United States, Mainland China, Taiwan and the Asia Pacific. It focuses on technology, healthcare, biotech, artificial intelligence, robotics, fintech, sustainability and new media, supporting portfolio companies from seed through growth rounds and working to help them scale globally through international collaboration.
The New Mexico Economic Development Department is dedicated to fostering economic growth in the state by implementing various programs designed to support and enhance business development. Through these initiatives, the department aims to create a favorable environment for new and existing businesses, thereby boosting job creation and overall economic vitality. The department's focus includes promoting investment opportunities and providing resources to help entrepreneurs navigate the challenges of starting and expanding their enterprises. By facilitating collaboration among stakeholders, the New Mexico Economic Development Department plays a crucial role in strengthening the state's economy and ensuring sustainable development.
Founded in 2014, this venture capital firm focuses on early-stage investments in life innovation, green innovation, and platform technology. Based in Osaka, Japan.
UCB is a Belgium-based biopharmaceutical company focused on developing therapies for central nervous system and immunology diseases. It maintains a broad portfolio across neurology and immunology, including treatments for epilepsy (Vimpat, Briviact, Keppra), Parkinson's disease and restless legs syndrome (Neupro), and autoimmune conditions such as inflammatory diseases (Cimzia) and psoriasis-related indications (bimekizumab, Evenity for osteoporosis). The company also markets medicines for allergies (Zyrtec, Xyzal), narcolepsy (Xyrem), and other conditions, and is pursuing innovative therapies such as Nayzilam for seizure clusters and newer agents like padsevonil, rozanolixizumab, UCB7858, UCB0599, and UCB0107. It engages in contract manufacturing and collaborates with academic and industry partners, including a multi-year collaboration with Stanford Medicine and partnerships with Sanofi, Amgen, Biogen, Otsuka, and doc.ai to advance patient value. Founded in 1928 and headquartered in Brussels, UCB integrates research, development, and manufacturing to address neurological and immune-related diseases worldwide.
Khosla Impact, established in 2013, is an impact investment firm based in Menlo Park, California. It focuses on assisting high-impact entrepreneurs who develop products and services for the three billion people at the bottom of the world's economic pyramid. The firm invests in for-profit enterprises serving low-income individuals and small businesses in emerging markets, with a primary focus on South Asia. Khosla Impact encourages experimentation and supports entrepreneurs passionate about solving socio-economic challenges through technology and innovative business models.
Verge HealthTech Fund, established in 2018 and based in Singapore, is a venture capital firm focused on early-stage investments in global healthcare technology companies. It targets innovative solutions that address disease prevention, management, and health system efficiency, with a particular relevance to emerging Asian markets. The firm seeks and supports visionary founders creating transformative healthtech companies, aiming to foster their growth and scale, regardless of their origin, from Dhaka's streets to Oxford's labs.
Founded in 2020, QantX is a venture capital firm headquartered in Bristol, UK. It focuses on investing in innovative startups across various sectors including healthcare, information technology, big data, clean technology, digital health, SaaS, artificial intelligence, climate tech, cybersecurity, HR tech, and IoT, primarily based in England.
MassChallenge is a global startup accelerator supporting early-stage entrepreneurs across various industries. Founded in 2009, it provides mentorship, resources, and networking opportunities through its programs worldwide.
Founded in 2001, Clarendon Fund Managers is a venture capital firm based in Belfast, Ireland. It specializes in investing in small and medium enterprises across various sectors, with a focus on Northern Ireland-based companies offering manufacturing or tradable services. The firm typically invests between £20,000 and £250,000 initially, with the potential for follow-on finance. Clarendon aims to exit its investments within five to seven years.
The National Institutes of Health (NIH) is a leading biomedical research facility in the United States, operating under the Department of Health and Human Services. Established in 1887 and based in Bethesda, Maryland, NIH is the primary agency responsible for biomedical and health-related research in the country. It comprises 27 separate institutes and centers, each focusing on different disciplines within biomedical science. NIH conducts its own scientific research through the Intramural Research Program and provides significant funding for research at external institutions via the Extramural Research Program. With a workforce that includes 1,200 principal investigators and over 4,000 postdoctoral fellows, NIH has been instrumental in major medical breakthroughs, such as the development of vaccines for hepatitis and human papillomavirus, as well as the discovery of treatments for various health conditions. As the world's largest source of medical research funding, NIH continues to advance scientific knowledge and contribute to public health improvements.
Ascension Health, a non-profit Catholic health system, operates a venture capital arm, Ascension Ventures, established in 2001. Based in Saint Louis, Missouri, with additional offices in London, Ascension Ventures invests in early to late-stage companies, focusing on healthcare and technology sectors. The firm targets a minimum investment of $0.318 million and a maximum of $1.912 million, typically exiting within 4 to 7 years. Ascension Ventures invests in areas such as healthcare services, devices, and technology, as well as financial technology, commerce, sustainability, and deep technology in the United Kingdom. The firm aims to deliver compassionate, personalized care to all, with a particular focus on those living in poverty and the most vulnerable.
Ah! Ventures, established in 2009 and headquartered in Mumbai, India, is a prominent platform facilitating early-stage startup fundraising. It connects over 3000 investors, including angels and institutions, with a robust pipeline of 600+ business plans monthly.
Founded in 2023, Empirical Ventures is a venture capital firm based in Bristol, UK. It focuses on investing in innovative life sciences, advanced materials, deep technology, robotics, and automation sectors.
Elevate Capital is a venture capital firm based in Hillsboro, Oregon, established in 2016. It focuses on seed and early-stage investments across the United States, with a regional emphasis on the Pacific Northwest and Portland metro area. The firm targets technology-enabled startups and seeks to diversify founder representation, supporting ventures founded by underrepresented entrepreneurs. Elevate Capital typically participates in early rounds and makes minority investments, providing more than capital through advisory support and access to networks to aid long-term growth. Portfolio scope includes software, life sciences, hardware, consumer products, fintech, healthcare, sustainability, and related technology sectors.
Life Science Angels, Inc. is a prominent angel investment group based in Sunnyvale, California, established in 2005. The organization specializes exclusively in healthcare investments, targeting sectors such as medical devices, diagnostics, pharmaceuticals, biotechnology, and digital health. Life Science Angels focuses on companies at various stages of development, including seed-stage, early-stage, and later-stage ventures. Through its investments, the group aims to support innovation and growth within the healthcare and life sciences industries.
Bpifrance is a financial institution dedicated to supporting companies throughout their development stages, particularly those preparing for stock market listing and seeking credit equity. The organization provides a range of financial solutions, including financing, innovation assistance, and capital investment. By integrating various entities such as OSEO and CDC Entreprises, Bpifrance aims to deliver tailored financial support that addresses the specific needs of businesses. The institution is committed to fostering innovation and helping companies transition toward sustainable growth, ensuring they are well-equipped to face future challenges.
Thiel Capital, established in 2011, is a venture capital firm based in West Hollywood, California. It focuses on investments across various industries, including artificial intelligence, drones, and healthcare, at seed, early, and later stages. The firm provides strategic and operational support for Peter Thiel's diverse investment initiatives and entrepreneurial ventures.
HAX is a global venture capital-backed program dedicated to accelerating startups with a hardware element. Operating in San Francisco and Shenzhen, HAX focuses on rapid prototyping and iteration, helping teams develop scalable business plans and secure funding.
Berkeley SkyDeck is a global startup accelerator affiliated with UC Berkeley, founded in 2012 and based in Berkeley, California. It offers a six-month cohort program, providing up to $100,000 in funding to accepted startups, with no industry restrictions. The accelerator offers mentorship, access to a vast network of advisors, industry partners, and alumni, and supports around 20 companies per cohort. Additionally, SkyDeck has a dedicated European fund, investing up to €145,000 in selected European startups.
Keysight Technologies is a prominent company in the electronic measurement sector, focusing on testing and measurement solutions for various industries, including communications, government, automotive, industrial, and semiconductor manufacturing. The company provides a range of software-centric design, simulation, and testing solutions aimed at helping original equipment manufacturers (OEMs) and suppliers meet industry standards and specifications. Keysight's offerings encompass testing tools, analytical software, and associated services, all designed to enhance efficiency and reduce time to market for its diverse customer base, which exceeds 30,000 clients. Through its innovative solutions, Keysight supports the development and deployment of advanced electronic products across multiple markets.
Established in 2020, the European Innovation Council supports innovative startups and researchers with promising ideas, focusing on early-stage companies with positive environmental, social, or governance impacts. It co-invests alongside private investors.
Techstars is a global platform that invests in and supports early-stage technology companies. Founded in 2006, it operates a mentorship-driven accelerator program, providing seed funding, intensive mentorship, and access to a network of investors and entrepreneurs. Techstars has programs in various locations worldwide, including Boston, Boulder, New York, Seattle, London, Chicago, and Austin. It invests $118,000 in each company, with $18,000 in seed funding and an optional $100,000 convertible debt note. Techstars also has industry-specific accelerator programs, such as Techstars Retail and Techstars Music, focusing on retail and music technology, respectively. Its portfolio includes over 1,000 companies with a combined market cap of $8.1 billion.
Atlantic Bridge, established in 2004, is a growth equity firm headquartered in Dublin with offices across Europe and the US. It invests in early-stage, deep technology companies in sectors such as cybersecurity, cloud, enterprise software, and health technology, primarily in the US, Europe, and Ireland. The firm's strategy focuses on partnering with ambitious entrepreneurs and management teams, providing capital and leveraging its global platform to facilitate international expansion. Atlantic Bridge's team comprises experienced entrepreneurs, technology industry executives, and investment professionals, offering a unique blend of international business experience and a collaborative approach to investing.
Furthr VC is the venture capital arm of Furthr, based in Dublin, Ireland. It focuses on early-stage investments in Irish companies that develop B2B software products and medical devices, spanning Seed to Series A rounds, with capital reserved for follow-on investments. The firm emphasizes relationship-driven, founder-centric partnerships and provides hands-on support across strategic areas to accelerate growth, backing born-global Irish software and medtech firms as they scale and pursue subsequent funding rounds.
The United States Air Force, established in 1947, is the aerial and space warfare service branch of the U.S. Armed Forces. With over 330,000 active personnel and a fleet of more than 5,000 aircraft, it maintains global air, space, and cyber superiority. The Air Force operates 63 satellites and has an annual budget of over US$ 140 billion. It has participated in numerous major conflicts worldwide and contributes significantly to global humanitarian relief efforts. The Air Force's mission is to "fly, fight, and win" in air, space, and cyberspace.
Desjardins Group, established in 1900, is a cooperative financial group based in Montreal, Canada. It offers a wide range of financial services to individuals and businesses, including personal banking, credit and loans, investments, insurance, and wealth management. Through its subsidiary, Desjardins Capital, the group provides venture capital and development capital to businesses and cooperatives across various sectors such as healthcare, manufacturing, technology, and agriculture. Desjardins Capital invests in startups, early-stage, and mature companies, typically providing equity or debt financing ranging from $0.09 million to $20 million for periods of 3 to 10 years. The group also offers corporate financing, debt capital markets, and equity capital markets services through its Desjardins Securities division.
EASME is a European Union executive agency that supports small and medium-sized enterprises and promotes innovation in Europe. It manages projects in the areas of small and medium-sized enterprises, as well as the environment, energy, and maritime sectors, funded by COSME, LIFE, and EMFF. EASME organizes the European Sustainable Energy Week and serves industries such as environmental management, energy production, and maritime activities.
LUMO Labs is an impact-driven venture capital firm and venture builder based in Eindhoven, Netherlands, with an office in Los Angeles. Founded in 2020, it backs early to growth-stage ventures through a multi-stage investment approach and operates a two-year growth program to accelerate founding teams. It emphasizes technologies such as AI, data, software, hardware, blockchain, robotics, drones, IoT, VR/AR and security, and focuses its portfolio on ventures aiming to solve social challenges. The firm prioritizes sectors including sustainable cities and communities, health and wellbeing, and quality education, offering startups access to capital, expertise, and an expansive network to help scale. By combining investment with hands-on support and collaboration, LUMO Labs seeks to advance startups that deliver measurable social and technological impact.
Jolt Capital is a Paris-based private equity firm that focuses on growth investments in mid-sized European technology companies. It targets software, hardware, mobility, cloud, IoT, artificial intelligence, cybersecurity, and related digital sectors, with typical revenues of 10 to 100 million euros and EBITDA up to about 40 million euros. The firm provides growth capital, working capital, and capital expenditure support to enable expansion, external growth, and balance-sheet strengthening, often through equity investments with board representation or minority stakes. Investments range approximately from 5 to 40 million euros, and deals are executed across Europe to accelerate scale, capabilities, and market reach. Founded in 2011 and headquartered in Paris, Jolt Capital operates as an independent investor focused on technology-driven growth, partnering with companies to drive profitability and geographic expansion.
Holland Capital, established in 1981, is a Dutch private equity firm headquartered in Amsterdam. It specializes in early-stage investments, primarily in the healthcare and technology sectors. The firm manages two active funds: one dedicated to supporting the growth of small and medium-sized enterprises (SMEs) in the Netherlands, and another focused on innovative healthcare businesses. Since its inception, Holland Capital has successfully realized over 115 investments.
Founded in 2008, Par Equity is a venture capital firm based in Edinburgh. It focuses on investing in early-stage, high-growth technology companies across Northern England, Northern Ireland, and Scotland.
Joyance Partners is a San Francisco–based venture capital firm that backs early-stage startups in technology, health tech, consumer, internet, and mobile sectors across North America, Europe, and Asia. Founded in 2012, the firm focuses on science and technology that enhance wellbeing and everyday joy, supporting companies from pre-seed to Series A. It seeks opportunities in information technology and life sciences, with an emphasis on ESG and health-related impact. The firm aims to empower individuals to improve their health, independence, and fulfillment through innovative products and services.